![](/img/cover-not-exists.png)
Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA{middle dot}CER) trial
Leonardi, S., Tricoci, P., White, H. D., Armstrong, P. W., Huang, Z., Wallentin, L., Aylward, P. E., Moliterno, D. J., Van de Werf, F., Chen, E., Providencia, L., Nordrehaug, J. E., Held, C., Strony,Volume:
34
Language:
english
Journal:
European Heart Journal
DOI:
10.1093/eurheartj/eht104
Date:
June, 2013
File:
PDF, 342 KB
english, 2013